Mouse Genome Engineering Using Designer Nucleases
Citations Over TimeTop 20% of 2014 papers
Abstract
Transgenic mice carrying site-specific genome modifications (knockout, knock-in) are of vital importance for dissecting complex biological systems as well as for modeling human diseases and testing therapeutic strategies. Recent advances in the use of designer nucleases such as zinc finger nucleases (ZFNs), transcription activator-like effector nucleases (TALENs), and the clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated (Cas) 9 system for site-specific genome engineering open the possibility to perform rapid targeted genome modification in virtually any laboratory species without the need to rely on embryonic stem (ES) cell technology. A genome editing experiment typically starts with identification of designer nuclease target sites within a gene of interest followed by construction of custom DNA-binding domains to direct nuclease activity to the investigator-defined genomic locus. Designer nuclease plasmids are in vitro transcribed to generate mRNA for microinjection of fertilized mouse oocytes. Here, we provide a protocol for achieving targeted genome modification by direct injection of TALEN mRNA into fertilized mouse oocytes.
Related Papers
- → Current and future delivery systems for engineered nucleases: ZFN, TALEN and RGEN(2014)123 cited
- → Comparing Zinc Finger Nucleases and Transcription Activator-Like Effector Nucleases for Gene Targeting in Drosophila(2013)72 cited
- → Biological and Biomedical Applications of Engineered Nucleases(2012)33 cited
- → Genome engineering with targetable nucleases (467.1)(2014)13 cited
- Programmable site-specific DNA endonucleases:powerful tools for genome engineering(2015)